This site uses cookies to improve your browsing experience. By using this site, you agree to their use. Cookie Information
6.1-point improvement in SGRQ quality of life score
(95%CI 3.7 to 8.6, P<0.0005)1
51% of patients achieved ≥5-point improvement in SGRQ1
57.6 m improvement in 6MWD immediately after
rehabilitation (95%CI 40.2 to 75.1 m, P<0.0005)1
65% of patients achieved MCID improvement in
dyspnoea1
52% of patients achieved MCID improvement in
depression score1
Numbers based on a prospective cohort study
SGRQ = St. George’s Respiratory Questionnaire, 6MWD = 6-minute walk distance, MCID = Minimum clinically important difference
Early supportive (palliative) care can help relieve symptoms and help maintain physical and emotional wellbeing in patients with progressive fibrosing ILD2
There is a broad range of approaches available to support patients with ILDs from pulmonary rehabilitation to mindfulness1-4
You can make a difference for your patients
1.
Ryerson CJ, Cayou C, Topp F, et al. Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort study. Respir Med. 2014;108(1):203-210.
2.
Kreuter M, Bendstrup E, Russell A, et al. Palliative care in interstitial lung disease: living well. Lancet Respir Med. 2017;5(12):968-980.
3.
Maher TM, Wuyts W. Management of Fibrosing Interstitial Lung Diseases. Adv Ther. 2019 May 22. doi: 10.1007/s12325-019-00992-9. [Epub ahead of print].
4.
Sgalla G, Cerri S, Ferrari R, et al. Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy. BMJ Open Respir Res. 2015;2(1):e000065.
Using this link will let you leave a website of Boehringer Ingelheim International GmbH (“BI”) or to a different domain under the control of BI. In the event that the linked site is not under the control of BI but under the control of a third party or an affiliate in the Boehringer Ingelheim group of companies, BI shall not be responsible for the contents, processing of personal data of any linked site or any link contained in a linked site, or any changes or updates to such sites. This link is provided to you only as a convenience, and the inclusion of any link does not imply endorsement by BI of the site.
This website is an international information resource intended for international healthcare professionals outside the United States of America (US) and the United Kingdom (UK) who are interested in information on pulmonary fibrosis.
By clicking on the link below you are declaring and confirming that you are a healthcare professional outside the US and UK and have read and understood this disclaimer.